BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21909138)

  • 1. MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma.
    Fan H; Chen L; Zhang F; Quan Y; Su X; Qiu X; Zhao Z; Kong KL; Dong S; Song Y; Chan TH; Guan XY
    Oncogene; 2012 May; 31(18):2298-308. PubMed ID: 21909138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of DNA methyltransferase 3b on FHIT expression and DNA methylation of the FHIT promoter region in hepatoma SMMC-7721 cells.
    Wang JX; Zhang YG; Zhao LS
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):273-7. PubMed ID: 19502167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
    Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.
    Chang HC; Cho CY; Hung WC
    Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.
    Wang J; Li J; Shen J; Wang C; Yang L; Zhang X
    BMC Cancer; 2012 Jun; 12():227. PubMed ID: 22681717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells.
    Yan MD; Yao CJ; Chow JM; Chang CL; Hwang PA; Chuang SE; Whang-Peng J; Lai GM
    Mar Drugs; 2015 Sep; 13(10):6099-116. PubMed ID: 26404322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential genes regulated by DNA methyltransferase 3B in a hepatocellular carcinoma cell line by RNA interference and microarray analysis.
    Xu J; Fan H; Zhao ZJ; Zhang JQ; Xie W
    Yi Chuan Xue Bao; 2005 Nov; 32(11):1115-27. PubMed ID: 16318277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.
    Butcher DT; Rodenhiser DI
    Eur J Cancer; 2007 Jan; 43(1):210-9. PubMed ID: 17071074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
    Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
    J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
    Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
    Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
    Yu J; Yuan X; Sjöholm L; Liu T; Kong F; Ekström TJ; Björkholm M; Xu D
    Cancer Lett; 2018 Oct; 434():33-41. PubMed ID: 30017965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antisense DNMT3b gene eukaryotic expression plasmid on expression of the DNMT3b gene in human biliary tract carcinoma cells.
    Zuo S; Dong JQ; Guo W; Liu MF; Xu LN; Luo J; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):123-8. PubMed ID: 16481298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.
    Long XR; He Y; Huang C; Li J
    Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma.
    Park HJ; Yu E; Shim YH
    Cancer Lett; 2006 Feb; 233(2):271-8. PubMed ID: 15885882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.